These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38748286)

  • 121. Usefulness of carbon-11-labeled methionine positron-emission tomography for assessing the treatment response of primary central nervous system lymphoma.
    Miyakita Y; Ohno M; Takahashi M; Kurihara H; Katai H; Narita Y
    Jpn J Clin Oncol; 2020 May; 50(5):512-518. PubMed ID: 32129443
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
    Houillier C; Soussain C; Ghesquières H; Soubeyran P; Chinot O; Taillandier L; Lamy T; Choquet S; Ahle G; Damaj G; Agapé P; Moluçon-Chabrot C; Amiel A; Delwail V; Fabbro M; Jardin F; Chauchet A; Moles-Moreau MP; Morschhauser F; Casasnovas O; Gressin R; Fornecker LM; Abraham J; Marolleau JP; Tempescul A; Campello C; Colin P; Tamburini J; Laribi K; Serrier C; Haioun C; Chebrek S; Schmitt A; Blonski M; Houot R; Boyle E; Bay JO; Oberic L; Tabouret E; Waultier A; Martin-Duverneuil N; Touitou V; Cassoux N; Kas A; Mokhtari K; Charlotte F; Alentorn A; Feuvret L; Le Garff-Tavernier M; Costopoulos M; Mathon B; Peyre M; Delgadillo D; Douzane H; Genet D; Aidaoui B; Hoang-Xuan K; Gyan E
    Neurology; 2020 Mar; 94(10):e1027-e1039. PubMed ID: 31907289
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Utility of FET-PET in detecting high-grade gliomas presenting with equivocal MR imaging features.
    Puranik AD; Boon M; Purandare N; Rangarajan V; Gupta T; Moiyadi A; Shetty P; Sridhar E; Agrawal A; Dev I; Shah S
    World J Nucl Med; 2019; 18(3):266-272. PubMed ID: 31516370
    [TBL] [Abstract][Full Text] [Related]  

  • 124.
    Michaud L; Beattie BJ; Akhurst T; Dunphy M; Zanzonico P; Finn R; Mauguen A; Schöder H; Weber WA; Lassman AB; Blasberg R
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1353-1367. PubMed ID: 31418054
    [TBL] [Abstract][Full Text] [Related]  

  • 125. 18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma.
    Bogsrud TV; Londalen A; Brandal P; Leske H; Panagopoulos I; Borghammer P; Bach-Gansmo T
    Clin Nucl Med; 2019 Aug; 44(8):605-611. PubMed ID: 31274605
    [TBL] [Abstract][Full Text] [Related]  

  • 126. 18F-FACBC PET/MRI in Diagnostic Assessment and Neurosurgery of Gliomas.
    Karlberg A; Berntsen EM; Johansen H; Skjulsvik AJ; Reinertsen I; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    Clin Nucl Med; 2019 Jul; 44(7):550-559. PubMed ID: 31107743
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [
    Law I; Albert NL; Arbizu J; Boellaard R; Drzezga A; Galldiks N; la Fougère C; Langen KJ; Lopci E; Lowe V; McConathy J; Quick HH; Sattler B; Schuster DM; Tonn JC; Weller M
    Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):540-557. PubMed ID: 30519867
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma.
    Ahn SY; Kwon SY; Jung SH; Ahn JS; Yoo SW; Min JJ; Bom HS; Ki SY; Kim HJ; Lee JJ; Song SY; Yang DH
    Clin Nucl Med; 2018 Aug; 43(8):e259-e264. PubMed ID: 29877882
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Characteristics of time-activity curves obtained from dynamic
    Nomura Y; Asano Y; Shinoda J; Yano H; Ikegame Y; Kawasaki T; Nakayama N; Maruyama T; Muragaki Y; Iwama T
    J Neurooncol; 2018 Jul; 138(3):649-658. PubMed ID: 29564749
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.
    Sun A; Liu X; Tang G
    Front Chem; 2017; 5():124. PubMed ID: 29379780
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Multimodal
    Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
    World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Diagnostic Performance and Safety of Positron Emission Tomography Using
    Wakabayashi T; Iuchi T; Tsuyuguchi N; Nishikawa R; Arakawa Y; Sasayama T; Miyake K; Nariai T; Narita Y; Hashimoto N; Okuda O; Matsuda H; Kubota K; Ito K; Nakazato Y; Kubomura K
    Asia Ocean J Nucl Med Biol; 2017; 5(1):10-21. PubMed ID: 28840134
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with
    Tsuyuguchi N; Terakawa Y; Uda T; Nakajo K; Kanemura Y
    Asia Ocean J Nucl Med Biol; 2017; 5(2):85-94. PubMed ID: 28660218
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Towards standardization of
    Unterrainer M; Vettermann F; Brendel M; Holzgreve A; Lifschitz M; Zähringer M; Suchorska B; Wenter V; Illigens BM; Bartenstein P; Albert NL
    EJNMMI Res; 2017 Dec; 7(1):48. PubMed ID: 28560582
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
    Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
    Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Suspected recurrence of brain metastases after focused high dose radiotherapy: can [
    Romagna A; Unterrainer M; Schmid-Tannwald C; Brendel M; Tonn JC; Nachbichler SB; Muacevic A; Bartenstein P; Kreth FW; Albert NL
    Radiat Oncol; 2016 Oct; 11(1):139. PubMed ID: 27769279
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
    Ceccon G; Lohmann P; Stoffels G; Judov N; Filss CP; Rapp M; Bauer E; Hamisch C; Ruge MI; Kocher M; Kuchelmeister K; Sellhaus B; Sabel M; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Neuro Oncol; 2017 Feb; 19(2):281-288. PubMed ID: 27471107
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Phase IIa clinical study of [
    Kondo A; Ishii H; Aoki S; Suzuki M; Nagasawa H; Kubota K; Minamimoto R; Arakawa A; Tominaga M; Arai H
    Ann Nucl Med; 2016 Nov; 30(9):608-618. PubMed ID: 27418267
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
    Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
    Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?
    Unterrainer M; Schweisthal F; Suchorska B; Wenter V; Schmid-Tannwald C; Fendler WP; Schüller U; Bartenstein P; Tonn JC; Albert NL
    J Nucl Med; 2016 Aug; 57(8):1177-82. PubMed ID: 27033893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.